Distributed Drug Discovery (D3) proposes solving large drug discovery problems by breaking them into smaller units for processing at multiple sites. A key component of the synthetic and computational stages of D3 is the global rehearsal of prospective reagents and their subsequent use in the creation of virtual catalogs of molecules accessible by simple, inexpensive combinatorial chemistry. The first section of this article documents the feasibility of the synthetic component of Distributed Drug Discovery. Twenty-fou
A strategic analysis of various issues which pertain to the enablement of combinatorial organic synt...
Amino acids are Nature's combinatorial building blocks. When substituted on both the amino and carbo...
poster abstractDistributed Drug Discovery (D3) is a multidisciplinary approach to identifying molecu...
Distributed Drug Discovery (D3) proposes solving large drug discovery problems by breaking them into...
Virtual molecular catalogs have limited utility if member compounds are (i) difficult to synthesize ...
There continues to be a need for innovative and inexpen-sive drugs to treat diseases of the developi...
We have successfully implemented the concept of Distributed Drug Discovery (D3) in the search for CN...
Through the collaboration of many institutions across the globe, the Distributed Drug Discovery proj...
An experiment for the synthesis of N-acyl derivatives of natural amino acids has been developed as p...
Amino acids are Nature’s combinatorial building blocks. When substituted on both the amino and carbo...
Several combinatorial methods have been developed to create focused or diverse chemical libraries wi...
The development of effective small-molecule probes and drugs entails a discovery phase, often requir...
The key objectives of medicinal chemistry are to efficiently design and synthesize bioactive compoun...
Introduction: Computational chemistry dramatically accelerates the drug discovery process and high-p...
The development of drugs is an expensive and time consuming activity. Current drug development progr...
A strategic analysis of various issues which pertain to the enablement of combinatorial organic synt...
Amino acids are Nature's combinatorial building blocks. When substituted on both the amino and carbo...
poster abstractDistributed Drug Discovery (D3) is a multidisciplinary approach to identifying molecu...
Distributed Drug Discovery (D3) proposes solving large drug discovery problems by breaking them into...
Virtual molecular catalogs have limited utility if member compounds are (i) difficult to synthesize ...
There continues to be a need for innovative and inexpen-sive drugs to treat diseases of the developi...
We have successfully implemented the concept of Distributed Drug Discovery (D3) in the search for CN...
Through the collaboration of many institutions across the globe, the Distributed Drug Discovery proj...
An experiment for the synthesis of N-acyl derivatives of natural amino acids has been developed as p...
Amino acids are Nature’s combinatorial building blocks. When substituted on both the amino and carbo...
Several combinatorial methods have been developed to create focused or diverse chemical libraries wi...
The development of effective small-molecule probes and drugs entails a discovery phase, often requir...
The key objectives of medicinal chemistry are to efficiently design and synthesize bioactive compoun...
Introduction: Computational chemistry dramatically accelerates the drug discovery process and high-p...
The development of drugs is an expensive and time consuming activity. Current drug development progr...
A strategic analysis of various issues which pertain to the enablement of combinatorial organic synt...
Amino acids are Nature's combinatorial building blocks. When substituted on both the amino and carbo...
poster abstractDistributed Drug Discovery (D3) is a multidisciplinary approach to identifying molecu...